Stuart Crow – Non Executive Chairman – Lake Resources N.L. (ASX:LKE, OTC: LLKKF) is a responsible lithium developer utilising state of-the-art ion exchange extraction technology for production of sustainable, high purity lithium from its flagship Kachi Project in Catamarca Province within the Lithium Triangle in Argentina. Lake also has three additional early-stage projects in this region.
Copyright 2024 – Finance News Network
08 Jul 2020 - Renergen Limited (ASX:RLT) Managing Director and CEO Stefano Marani talks about the company's high concentration of helium from Phase 1 drill results at its Virginia Gas Field in the Karoo Basin, South Africa.
18 Mar 2020 - First Graphene Limited (ASX:FGR) Executive Director and CFO, Peter Youd, talks about the company's 1H20 results, progress with key customer trials and work at the Graphene Engineering & Innovation Centre (GEIC) in Manchester, UK.
01 Mar 2023 - Immutep Limited (ASX:IMM) Executive Director and CEO Marc Voigt discusses data from SITC, the strategy to take Efti to market and milestones for 2023.
21 Mar 2022 - Austco Healthcare Limited (ASX:AHC) CEO Clayton Astles provides an overview of the company, discussing technology and products, supply chain management, revenue and outlook.
05 Apr 2023 - North Stawell Minerals Limited (ASX:NSM) CEO Russell Krause provides an update, discussing the company's progress to date, the most prospective targets, and milestones ahead.
30 Jul 2021 - Novatti Group Limited (ASX:NOV) CEO, Peter Cook, provides an update on activities from the company's June quarter, discussing growth in platforms and infrastructure and the recent capital raise.
29 Feb 2024 - Michael Spreadborough - Executive Co-Chairman - NOVO Resources (ASX:NVO) is a gold explorer with one of the largest prospective gold and battery metals land packages in the Pilbara, a premier exploration and mining region located in Western Australia.
10 Mar 2020 - Opthea Limited (ASX:OPT) Managing Director and CEO, Dr Megan Baldwin talks about results from the company's lead drug candidate OPT-302, and new funding for further clinical development for wet AMD (age-related macular degeneration) and DME (diabetic macular degeneration).
03 Dec 2019 - EQT Holdings Limited (ASX:EQT) Managing Director, Mick O'Brien talks FY19 results, market conditions, contribution from recent acquisitions and outlook for 1H20.
26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
